The Artisan International Explorer Fund has reported a strong performance in the second quarter, demonstrating an impressive 17.1% return, which notably surpassed the benchmark's 9.6% increase. This period saw strategic adjustments to the fund's holdings, including the acquisition of Shimadzu in Japan and the divestment of Vitrocell and Pluxee. The top-performing assets contributing to this success were IQE, Glenveagh, and Vitrocell, while Essentra, AdvancedAdvT, and Medmix were identified as the primary underperformers for the quarter.
The investment philosophy underpinning these results is centered on a meticulous process of identifying high-quality, yet undervalued, businesses. The fund primarily targets non-U.S. equities with market capitalizations below $5 billion, aiming to uncover opportunities that promise superior risk-adjusted returns. A core tenet of this strategy involves a comprehensive analysis to ascertain the intrinsic value of potential investments, ensuring that each addition to the portfolio aligns with the fund's stringent quality and valuation criteria.
This quarter's positive outcomes underscore the efficacy of a disciplined investment approach focused on fundamental value. By consistently adhering to its strategy of seeking out high-potential, underpriced assets globally, the fund aims to deliver sustained growth for its investors. The ability to outperform the market amidst various economic conditions highlights the team's expertise in navigating international equity markets and making astute investment decisions.
